Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Health disparities in breast cancer: biology meets socioeconomic status.

Dunn BK, Agurs-Collins T, Browne D, Lubet R, Johnson KA.

Breast Cancer Res Treat. 2010 Jun;121(2):281-92. doi: 10.1007/s10549-010-0827-x. Epub 2010 May 1. Review.

PMID:
20437200
2.

Epidemiology of health disparities in relation to the biology of estrogen receptor-negative breast cancer.

Agurs-Collins T, Dunn BK, Browne D, Johnson KA, Lubet R.

Semin Oncol. 2010 Aug;37(4):384-401. doi: 10.1053/j.seminoncol.2010.05.002. Review.

PMID:
20816508
4.
5.

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.

Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SG, Eley JW.

Breast Cancer Res Treat. 2009 Jan;113(2):357-70. doi: 10.1007/s10549-008-9926-3. Epub 2008 Mar 7.

PMID:
18324472
6.

Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.

Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

J Surg Res. 2007 Nov;143(1):109-18.

PMID:
17950079
8.

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.

Elledge RM, Clark GM, Chamness GC, Osborne CK.

J Natl Cancer Inst. 1994 May 4;86(9):705-12.

PMID:
7908990
9.

What is triple-negative breast cancer?

Irvin WJ Jr, Carey LA.

Eur J Cancer. 2008 Dec;44(18):2799-805. doi: 10.1016/j.ejca.2008.09.034. Epub 2008 Nov 12. Review.

PMID:
19008097
10.

African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics.

Jones BA, Kasl SV, Howe CL, Lachman M, Dubrow R, Curnen MM, Soler-Vila H, Beeghly A, Duan F, Owens P.

Cancer. 2004 Sep 15;101(6):1293-301.

11.

Disparities in medical care among commercially insured patients with newly diagnosed breast cancer: opportunities for intervention.

Short LJ, Fisher MD, Wahl PM, Kelly MB, Lawless GD, White S, Rodriguez NA, Willey VJ, Brawley OW.

Cancer. 2010 Jan 1;116(1):193-202. doi: 10.1002/cncr.24691.

12.

Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes: a population-based study and first report.

Lund MJ, Butler EN, Hair BY, Ward KC, Andrews JH, Oprea-Ilies G, Bayakly AR, O'Regan RM, Vertino PM, Eley JW.

Cancer. 2010 Jun 1;116(11):2549-59. doi: 10.1002/cncr.25016.

13.

Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer.

Du XL, Fang S, Meyer TE.

Am J Clin Oncol. 2008 Apr;31(2):125-32. doi: 10.1097/COC.0b013e3181587890.

PMID:
18391595
14.

Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer.

Dignam JJ, Wieand K, Johnson KA, Raich P, Anderson SJ, Somkin C, Wickerham DL.

Breast Cancer Res Treat. 2006 Jun;97(3):245-54. Epub 2005 Dec 6.

PMID:
16331345
15.

Social determinants of Black-White disparities in breast cancer mortality: a review.

Gerend MA, Pai M.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):2913-23. doi: 10.1158/1055-9965.EPI-07-0633. Review.

16.

Impact of race and ethnicity on outcomes for estrogen receptor-negative breast cancers: experience of an academic center with a charity hospital.

Chu QD, Burton G, Glass J, Smith MH, Li BD.

J Am Coll Surg. 2010 May;210(5):585-92, 592-4. doi: 10.1016/j.jamcollsurg.2010.01.025.

PMID:
20421009
17.

Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic white women. An analysis of 13,239 cases.

Gapstur SM, Dupuis J, Gann P, Collila S, Winchester DP.

Cancer. 1996 Apr 15;77(8):1465-71.

18.

Racial differences in the incidence of breast cancer subtypes defined by combined histologic grade and hormone receptor status.

Cunningham JE, Montero AJ, Garrett-Mayer E, Berkel HJ, Ely B.

Cancer Causes Control. 2010 Mar;21(3):399-409. doi: 10.1007/s10552-009-9472-2. Epub 2009 Dec 19.

PMID:
20024610
19.

Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?

Keating NL, Kouri E, He Y, Weeks JC, Winer EP.

Med Care. 2009 Jul;47(7):765-73. doi: 10.1097/MLR.0b013e31819e1fe7.

PMID:
19536008
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk